Judy Kay Frieder, CEAC, CSA, ECHMP, CLIPP’s Post

Great news for the #bostonmetro #biotech and #pharma industries driving innovation and new therapeutic research. The reauthorizing of the Life Sciences Initiative promises to build on the success of the program that has made Massachusetts a global leader in this critical industry. #lifesciencesindustry #lifesciecesinitiative #innovation #researchanddevelopment #massbio

Great news for the #bostonmetro #biotech and #pharma industries driving innovation and new therapeutic research. The reauthorizing of the Life Sciences Initiative promises to build on the success of the program that has made Massachusetts a global leader in this critical industry. #lifesciencesindustry #lifesciecesinitiative #innovation #researchanddevelopment #massbio

📢 ALERT RESEARCH GRANT OPPORTUNITY - Surrey Academic Health and Care Partnership (SAHCP) Energise Fund, will support evidence-based, multidisciplinary projects of a value between £50,000–£75,000. 🔦 If you need to improve your grant writing skills I'm running an online workshop on 19th September from 8.30 - 10am. Drop me a comment or message if you'd like more info. Summary of Energise Fund - need to be UK organisations based in Surrey and lead applicant needs to be NHS organisation, higher education institution or Surrey County Council within SAHCP area. Closing date - 25th September 2024. The fund seeks to improve healthcare services in ‘out-of-hospital’ settings to deliver care that’s more cost-effective and convenient for patients. It also focuses on early detection in healthcare by advancing preventative care to effectively address health risks before they escalate.  https://lnkd.in/eagXRx64

🚀 "Triumphs & Trials: Young Medical Delta's Bold Leap from Setbacks to Thesis Awards Success!" 🌟 In every journey, especially one driven by innovation and ambition, setbacks and mistakes are not just inevitable – they're essential. Today, we want to share a story of resilience, learning, and ultimately, triumph. 🔄 A Lesson in Adaptation Back in September, we faced a challenge. Our planned Thesis Awards had to be postponed due to fewer sign-ups than anticipated. It was a moment of reflection for us at Young Medical Delta. Yes, we could have done some things better. And that's exactly what we set out to do. 💡 Young at Heart, Rich in Learning Our name, 'Young' Medical Delta, isn't just a title. It symbolizes our ethos. Being 'young' means constantly evolving, embracing the growth that comes from every experience, and yes, learning from our mistakes. We are a community that is youthful, not just in age, but in spirit – resilient, adaptable, and ever-learning. 🚀 The Power of Resilience We promised ourselves that we would come back stronger, and we did. With renewed energy and strategies, we turned a setback into an opportunity for growth. The result? A record number of sign-ups for the rescheduled Thesis Awards on January 18, 2024. This isn't just a number; it's a testament to our community's belief in us and our mission. 🚀 Looking Forward to Our Next Mistakes Yes, you read that right! We are looking forward to our next mistakes – each one is an opportunity to grow, innovate, and push boundaries. Bring it on, because with every challenge, we become stronger, wiser, and more prepared for the future. 🎉 Raising a Toast to Your 2023 Missteps! Mistakes in 2023? Tell us about them, and let's have a toast! In the world of Young Medical Delta, every slip-up is a confetti moment in our shared journey of growth and learning. Here's to more breakthroughs, shared learning experiences, and, most importantly, toasting to every lesson learned along the way! 🥂 #Resilience #GrowthMindset #LearningFromSetbacks #ThesisAwards #YoungMedicalDelta #InnovationJourney

I’m continuously impressed by the outstanding leadership at iRhythm Technologies, Inc. One particular stand out is Paula Miller, Director of DEI. She recently presented at our Global Sales Meeting on identifying your own implicit bias and the impact it can have on others around you. It’s fantastic to see industry taking initiatives for this important discussion. As health professionals, we also need to take the time to better understand implicit bias as it directly relates to patient care outcomes. I’d highly recommend taking the time to understand your own implicit bias through taking Project Implicit’s exam: https://lnkd.in/gjmjCh-N. Closing the disparity gap in healthcare can only be achieved if we are able to understand the role our own implicit bias has in preventing us from delivering equitable patient care.

🗽 “National Importance” in EB-2 NIW: What You Need to Know 🗽 When applying for an EB-2 NIW, your proposed endeavor must demonstrate substantial merit and national importance. This can span across various fields like business, science, technology, health, education, and more. 🔍 Two Key Categories 🔍 Your endeavor can generally fall into two categories: 1️⃣ Research-Based Endeavors USCIS evaluates the impact of your past work on the industry. They focus on factors like the number of citations, letters of recommendation, and other evidence of your work’s influence. 2️⃣ Other Endeavors (Entrepreneurial, Professional) For non-research endeavors, USCIS places greater emphasis on the future impact of your work. It’s more about what you will achieve rather than what you’ve already done. 🔎 How to Determine if Your Endeavor Has Substantial Merit and National Importance 🔎 Forget about Substantial Merit – It is almost never challenged by USCIS. National Importance – Focus on identifying a significant problem in the U.S. that your endeavor can help resolve, whether it’s ecological, industrial, or social. If your work can substantially contribute to solving or alleviating this issue, you’re likely meeting the first criterion: substantial merit and national importance. 💡 Pro Tip: If you can’t ensure a significant number of citations for your academic work, consider focusing on business or other non-research endeavors for your EB-2 NIW application. 📞 Call us today at +1 (484) 450-8184 for a consultation, or click the link to schedule a consultation at www.premierimmigration.us now!

Highlighting this work led by my colleague, Will Cragg, about developing resources for participants who withdraw from clinical trials. Stopping participation can be a tough process for participants. People have reported feeling 'abandoned', or find it difficult to communicate reasons for stopping participation, or communication from research staff about what happens as a result of stopping participation, makes it more difficult. But the work hadn't really been explored in depth, and we found that sometimes participants can be excluded from important communications like study results without clear justification. A co-developed resource to provide support to research participants who stop taking part was produced. I really enjoyed being involved, particularly being led by Will and watching him manage this project with a group of public contributors whose experience and skills were essential to informing the direction of the work. Have a read and check out the PeRSEVERE website, developed by Will, for guidance and resources for handling end of participation https://lnkd.in/e__Fr-9U Full paper here: https://lnkd.in/e4MJn39S #trialconduct #ppie #clinicaltrials #research

🚀 Are you curious about the SCTO's activities in 2023? In 2023, the #SCTO and its #Network continued on their mission to enable high-quality clinical research. Our Annual Report 2023 highlights the key activities across several important areas. Looking ahead, the SCTO will further its mission in the research community by: 🔗 Fostering and intensifying collaboration between national research infrastructures 🔗 Strengthening the CTU Network 🔗 Increasing the harmonisation of clinical research through tools, guidance, and relevant services Read more about our achievements, milestones, and visions for the future in our Annual Report 2023! 📊✨ https://lnkd.in/eP6_jM_8

Are you planning to apply for an SBIR/STTR at NIH or NSF in 2024? Join the SBTDC Technology Commercialization Team and Superior Medical Experts on Wednesday, February 21 from Noon to 4:00PM for an intensive, no-cost session to help educate and prepare you for a Phase 1 SBIR/STTR proposal submission to NIH and NSF in 2024. Free and open to the public. Generously sponsored by Hutchison PLLC. Topics Include: -SBIR/STTR Program Overview -North Carolina Incentive and Match funding -Planning for Phase 1 Submission -Proposal Content and Guidance -Awardee Panel Session -Post-Submission Review Process -Access to our 12 Week Proposal Prep Guide -Follow-on Services to Assist You Register: https://ow.ly/EtFS50QrXCE #YourBusinessBetter #SBTDC #SBIR #STTR #NIH #NSF #smallbusiness #innovation #technology #funding #entrepreneurship #research

They say insanity is doing the same thing repeatedly and expecting different results... This is true for clinical trials with 𝗼𝘃𝗲𝗿𝗿𝗲𝗹𝗶𝗮𝗻𝗰𝗲 𝗼𝗻 𝘁𝗵𝗲 𝘀𝗮𝗺𝗲 𝗽𝗿𝗼𝘁𝗼𝗰𝗼𝗹𝘀, 𝘀𝗶𝘁𝗲𝘀, 𝗮𝗻𝗱 𝗿𝗲𝗰𝗿𝘂𝗶𝘁𝗺𝗲𝗻𝘁 𝗺𝗲𝘁𝗵𝗼𝗱𝘀. Suppose your past trials faced enrollment issues, and you replicated the same trial design, sites, and recruitment methods without analysis. In that case, you're passing the same problem to another study. Isn’t this insanity? 𝗬𝗼𝘂 𝗠𝗨𝗦𝗧 𝗰𝗵𝗮𝗻𝗴𝗲 𝗵𝗼𝘄 𝘆𝗼𝘂 𝘁𝗵𝗶𝗻𝗸 𝗮𝗻𝗱 𝗮𝗰𝘁 𝗶𝗳 𝘆𝗼𝘂 𝘄𝗮𝗻𝘁 𝗯𝗲𝘁𝘁𝗲𝗿 𝘁𝗿𝗶𝗮𝗹 𝗲𝗻𝗿𝗼𝗹𝗹𝗺𝗲𝗻𝘁. #clinicaltrials #innovation #patientcentric #clinicalresearch ________ I help small life science companies overcome enrollment issues| Insightful Intellect Let's chat! -https://lnkd.in/gAWvdZwz